Delivery Order SPE2DB20D1109-SPE2DB24FP35J
Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $7,395.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Activase 100 mg vials, a critical medical product. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,683.72 firm fixed-price delivery order is for the supply of ACTIVASE 50 MG VIALS, a medical product, with a performance period extending to July 9, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,187.42 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTIVASE 50 MG VIALS. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This federal contract award, valued at $8,578.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of ACTIVASE 100 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds...
- This federal contract award is for the delivery of Activase 50 mg vials to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense (DOD) and Veterans Affairs (VA). The contract, valued at $2,864.71, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
- This federal contract award is for the delivery of Activase 50 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,864.71, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,927.44 fixed-price delivery order covers the supply of 50 mg vials of the drug Activase, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a $3,198.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 50 mg vials of the drug Activase. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This federal contract award, valued at $11,871.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a delivery order for 4,568,055,020 units of Activase 50 mg vials, a medication used for the treatment of ischemic strokes. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 29, 2025. AmerisourceBergen Drug Corporation holds a substantial Indefinite Delivery...
- This federal contract award, valued at $11,199.17, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a completion date of January 9, 2025. The contract has a Firm Fixed Price...